Current Market Information

Last Trade Price (LTP) 12.20 Last Trade Date 10 December, 2025 Change -0.81 % Open Price 12.30 Day's Range 12.10 - 12.20     Total Trade 2 Total Volume 14000 Close Price 12.20 Yesterday Close Price 12.30 Market Capital in BDT (mn) 1417.703

Contact Information

Designation Name Mobile Number Email Chairman Mrs. Hafiza Yeasmin 01731936799 hafizaibpl@gmail.com MD A. F. M. Anowarul Huq 01711345816 sabila707@gmail.com CFO Md. Faruque Hossain 01883011125 cfoibpl@gmail.com Company Secretary Mohi Uddin 01777685176 mahfuzdk85@yahoo.com Office Address Plot-183 (7th Floor), Block-B, Ahmed Akber Sobhan Road, Bashundhara R/A, Dhaka-1229. Phone : 09678777995 Fax : Email : info@indo-banglapharma.com Website : http://www.indo-banglapharma.com Factory Address 729, BM College Road, Barishal Sadar, Barishal-8200

Basic Information

Authorized Capital in BDT* (mn) 1,500.00 Paid-up Capital in BDT* (mn) 1,162.05 Face Value 10 Paid up Share 116205178     Market Lot 1 Sector PHARMA & CHEMICALS Market Category B

Other Information

Listing Year 2018 Debut Trade Date 18 October, 2018 Type of Instrument     52 Week's Range 8.70 - 14.70 Year End 30 June Reserve / Surplus(mn) 418.79 Remarks Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 30-Sep, 2025 24.43 0 17.4 0 58.17 As on 31-Aug, 2025 24.43 0 20.6 0 54.97 As on 31-May, 2025 24.43 0 17.85 0 57.72 As on 30-Jun, 2025 (year ended) 24.43 0 22.74 0 52.83     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Nov 06, 2024 BBB ST-3 Stable Nov 25, 2025 Emerging Credit Rating Ltd Nov 06, 2023 BBB ST-3 Stable Nov 05, 2024 Emerging Credit Rating Ltd Nov 06, 2022 BBB ST-3 Stable Nov 05, 2023 Emerging Credit Rating Ltd         Half Year End (HY) Information  202412 HY Net Turnover(mn)   HY Net Profit after tax(mn)   HY EPS  -0.08  AGM Information   AGM Date  30 December, 2025 Record Date  07 December, 2025 Dividend(%)  0.15 (June 2025) Bonus Issue  3%-2021,2%-2020,9%-2019, 10%-2018

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2024	-0.35	0	0	0	13.6	0	-40.98	0	0.1C%	0.08
2023	0.07	0	0	0	13.96	0	8.41	0		0
2022	0.22	0	0	0	13.98	0	25.17	0	1%C	0.56
2021	1.18	0	0	0	14.29	0	134.73	0	4%C,3%B	2.02
2020	1.4	0	0	0	13.61	0	156.24	0	4.5%C,2%B	2.18

Financial Statements
Quarterly Financial Statement	https://www.indo-banglapharma.com/site/investor?cat=Quarterly Report
Price Sensitive Information	https://www.indo-banglapharma.com/site/investor?cat=PSI

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To